» Articles » PMID: 38132724

Apicomplexan Phosphodiesterases in Cyclic Nucleotide Turnover: Conservation, Function, and Therapeutic Potential

Overview
Journal mBio
Specialty Microbiology
Date 2023 Dec 22
PMID 38132724
Authors
Affiliations
Soon will be listed here.
Abstract

Apicomplexa encompasses a large number of intracellular parasites infecting a wide range of animals. Cyclic nucleotide signaling is crucial for a variety of apicomplexan life stages and cellular processes. The cyclases and kinases that synthesize and respond to cyclic nucleotides (i.e., 3',5'-cyclic guanosine monophosphate and 3',5'-cyclic adenosine monophosphate) are highly conserved and essential throughout the parasite phylum. Growing evidence indicates that phosphodiesterases (PDEs) are also critical for regulating cyclic nucleotide signaling via cyclic nucleotide hydrolysis. Here, we discuss recent advances in apicomplexan PDE biology and opportunities for therapeutic interventions, with special emphasis on the major human apicomplexan parasite genera , , , and . In particular, we show a highly flexible repertoire of apicomplexan PDEs associated with a wide range of cellular requirements across parasites and lifecycle stages. Despite this phylogenetic diversity, cellular requirements of apicomplexan PDEs for motility, host cell egress, or invasion are conserved. However, the molecular wiring of associated PDEs is extremely malleable suggesting that PDE diversity and redundancy are key for the optimization of cyclic nucleotide turnover to respond to the various environments encountered by each parasite and life stage. Understanding how apicomplexan PDEs are regulated and integrating multiple signaling systems into a unified response represent an untapped avenue for future exploration.

Citing Articles

Identification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised male mice.

Ajiboye J, Teixeira J, Gasonoo M, Mattice E, Korwin-Mihavics B, Miller P Nat Commun. 2024; 15(1):8272.

PMID: 39333545 PMC: 11436873. DOI: 10.1038/s41467-024-52658-y.


Proteomic approaches for protein kinase substrate identification in Apicomplexa.

Cabral G, Moss W, Brown K Mol Biochem Parasitol. 2024; 259:111633.

PMID: 38821187 PMC: 11194964. DOI: 10.1016/j.molbiopara.2024.111633.

References
1.
Barylyuk K, Koreny L, Ke H, Butterworth S, Crook O, Lassadi I . A Comprehensive Subcellular Atlas of the Toxoplasma Proteome via hyperLOPIT Provides Spatial Context for Protein Functions. Cell Host Microbe. 2020; 28(5):752-766.e9. PMC: 7670262. DOI: 10.1016/j.chom.2020.09.011. View

2.
Brown K, Long S, Sibley L . Plasma Membrane Association by N-Acylation Governs PKG Function in . mBio. 2017; 8(3). PMC: 5414004. DOI: 10.1128/mBio.00375-17. View

3.
Harker K, Ueno N, Lodoen M . Toxoplasma gondii dissemination: a parasite's journey through the infected host. Parasite Immunol. 2014; 37(3):141-9. DOI: 10.1111/pim.12163. View

4.
Vo K, Ruga L, Psathaki O, Franzkoch R, Distler U, Tenzer S . Plasticity and therapeutic potential of cAMP and cGMP-specific phosphodiesterases in . Comput Struct Biotechnol J. 2022; 20:5775-5789. PMC: 9619220. DOI: 10.1016/j.csbj.2022.09.022. View

5.
Baillie G, Tejeda G, Kelly M . Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond. Nat Rev Drug Discov. 2019; 18(10):770-796. PMC: 6773486. DOI: 10.1038/s41573-019-0033-4. View